• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1例患者经镓- DOTATATE PET/CT检查发现的促尿磷排泄间叶肿瘤:病例报告

Phosphaturic mesenchymal tumor demonstrated by Ga-DOTATATE PET/CT in a patient: a case report.

作者信息

Abadi Younes, Mileva Magdalena, Léger Marc-André, Sidiras Paschalis, Artigas Carlos, Flamen Patrick, Karfis Ioannis

机构信息

Department of Nuclear Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

Department of Rheumatology and Physical Medicine, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.

出版信息

EJNMMI Rep. 2024 Sep 18;8(1):30. doi: 10.1186/s41824-024-00219-3.

DOI:10.1186/s41824-024-00219-3
PMID:39289324
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11408431/
Abstract

Tumor-induced osteomalacia (TIO) is a paraneoplastic syndrome caused by abnormally high levels of fibroblast growth factor 23 (FGF-23), most commonly produced and secreted by small phosphaturic mesenchymal tumors (PMT). These tumors can show various anatomic locations throughout soft tissue and bone. The presence of the tumor itself rarely causes symptoms. Nonspecific symptoms such as muscle weakness and musculoskeletal pain are related to the developing hypophosphatemia and osteomalacia as a secondary effect of the increased circulating levels of FGF-23. Therefore, as the initial presentation can mimic a wide range of metabolic or inflammatory diseases, proper diagnosis is often delayed. Localization of the tumor is crucial, as its complete surgical resection is the only curative treatment. Whole-body functional imaging targeting the overexpression of somatostatin receptors (SSTR) on the surface of the PMT cells, is a highly specific and sensitive imaging method to detect the primary tumor site. Here, we discuss a case of TIO in a patient initially presenting with symptoms of inflammatory spondyloarthritis. SSTR positron emission imaging using 68Ga-DOTATATE was central in diagnosing and localizing the primary tumor.

摘要

肿瘤诱导的骨软化症(TIO)是一种副肿瘤综合征,由成纤维细胞生长因子23(FGF-23)水平异常升高引起,最常见于由小的磷尿性间叶肿瘤(PMT)产生和分泌。这些肿瘤可出现在整个软组织和骨骼的不同解剖位置。肿瘤本身很少引起症状。诸如肌肉无力和肌肉骨骼疼痛等非特异性症状与FGF-23循环水平升高的继发效应——低磷血症和骨软化症的发展有关。因此,由于初始表现可模仿多种代谢或炎症性疾病,正确诊断往往延迟。肿瘤的定位至关重要,因为其完整的手术切除是唯一的治愈性治疗方法。针对PMT细胞表面生长抑素受体(SSTR)过表达的全身功能成像,是检测原发肿瘤部位的一种高度特异性和敏感性的成像方法。在此,我们讨论一例最初表现为炎性脊柱关节炎症状的TIO患者。使用68Ga-DOTATATE的SSTR正电子发射成像在诊断和定位原发肿瘤方面起了关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8e1/11408431/59c20fda3e58/41824_2024_219_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8e1/11408431/89a73dbaa8ac/41824_2024_219_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8e1/11408431/6e4342a61511/41824_2024_219_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8e1/11408431/59c20fda3e58/41824_2024_219_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8e1/11408431/89a73dbaa8ac/41824_2024_219_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8e1/11408431/6e4342a61511/41824_2024_219_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8e1/11408431/59c20fda3e58/41824_2024_219_Fig3_HTML.jpg

相似文献

1
Phosphaturic mesenchymal tumor demonstrated by Ga-DOTATATE PET/CT in a patient: a case report.1例患者经镓- DOTATATE PET/CT检查发现的促尿磷排泄间叶肿瘤:病例报告
EJNMMI Rep. 2024 Sep 18;8(1):30. doi: 10.1186/s41824-024-00219-3.
2
Ga-DOTATATE positron emission tomography/computed tomography to detect the recurrence of phosphaturic mesenhcymal tumor-induced osteomalacia.镓- DOTATATE正电子发射断层扫描/计算机断层扫描用于检测磷尿性间叶肿瘤诱导的骨软化症的复发。
World J Nucl Med. 2019 Jul 23;19(1):78-81. doi: 10.4103/wjnm.WJNM_92_18. eCollection 2020 Jan-Mar.
3
Comparison of F-FDG PET/CT and Ga-DOTATATE PET/CT in the Targeted Imaging of Culprit Tumors Causing Osteomalacia.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描与镓- DOTATATE 正电子发射断层扫描/计算机断层扫描在致佝偻病罪犯肿瘤靶向成像中的比较。
Orthop Surg. 2021 May;13(3):791-798. doi: 10.1111/os.12980. Epub 2021 Mar 11.
4
Tumor-induced osteomalacia treated with T12 tumor resection.经T12肿瘤切除治疗的肿瘤诱导性骨软化症
Endocrinol Diabetes Metab Case Rep. 2022 Dec 1;2022. doi: 10.1530/EDM-22-0344.
5
Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET/CT.用镓-68 DOTATATE PET/CT 提高肿瘤性骨软化症的诊断。
J Clin Endocrinol Metab. 2013 Feb;98(2):687-94. doi: 10.1210/jc.2012-3642. Epub 2013 Jan 7.
6
Unusual phosphaturic mesenchymal tumor mimicking osteoid osteoma.模仿骨样骨瘤的罕见促排磷间叶肿瘤。
Radiol Case Rep. 2023 Jun 3;18(8):2738-2743. doi: 10.1016/j.radcr.2023.05.008. eCollection 2023 Aug.
7
Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation.经影像引导消融治疗引起骨软化症的持续性磷质间叶性肿瘤。
Osteoporos Int. 2021 Sep;32(9):1895-1898. doi: 10.1007/s00198-020-05795-1. Epub 2021 Mar 2.
8
Extended Whole-body Ga-68 DOTATATE PET-CT in evaluating Tumour-Induced Osteomalacia: Case report and review of literature.镓-68 DOTATATE 全身PET-CT在评估肿瘤诱导的骨软化症中的应用:病例报告及文献复习
Nucl Med Mol Imaging. 2021 Jun;55(3):130-135. doi: 10.1007/s13139-021-00695-6. Epub 2021 Apr 19.
9
Comparison of 18F-FDG and 68Ga DOTATATE PET/CT in localization of tumor causing oncogenic osteomalacia.18F-FDG 和 68Ga-DOTATATE PET/CT 对肿瘤致成瘤性骨软化症定位的比较。
Clin Nucl Med. 2015 Jan;40(1):e6-e10. doi: 10.1097/RLU.0000000000000460.
10
A diagnostic challenge of mysterious bone pain caused by tumor-induced osteomalacia with multiple tumors: a case report.肿瘤诱导性骨软化症合并多发肿瘤所致神秘骨痛的诊断挑战:一例报告
Transl Cancer Res. 2023 Feb 28;12(2):413-420. doi: 10.21037/tcr-22-2116. Epub 2023 Feb 3.

引用本文的文献

1
Tumor-induced osteomalacia secondary to phosphaturic mesenchymal tumor: a case description and literature analysis.肿瘤诱导的骨软化症继发于磷尿性间叶肿瘤:病例描述与文献分析
Quant Imaging Med Surg. 2025 Jun 6;15(6):5900-5909. doi: 10.21037/qims-24-2278. Epub 2025 May 30.
2
Role of Positron Emission Tomography (PET) in the Diagnosis of Musculoskeletal Disorders.正电子发射断层扫描(PET)在肌肉骨骼疾病诊断中的作用
J Clin Med. 2025 Apr 29;14(9):3080. doi: 10.3390/jcm14093080.

本文引用的文献

1
Intracranial Phosphaturic Mesenchymal Tumor Detected by 68 Ga-DOTATATE PET/CT.颅内磷酸化解质肿瘤经 68Ga-DOTATATE PET/CT 检测。
Clin Nucl Med. 2024 May 1;49(5):459-461. doi: 10.1097/RLU.0000000000005066. Epub 2024 Jan 24.
2
Comparison of F-FDG PET/CT and Ga-DOTATATE PET/CT in the Targeted Imaging of Culprit Tumors Causing Osteomalacia.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描与镓- DOTATATE 正电子发射断层扫描/计算机断层扫描在致佝偻病罪犯肿瘤靶向成像中的比较。
Orthop Surg. 2021 May;13(3):791-798. doi: 10.1111/os.12980. Epub 2021 Mar 11.
3
Usefulness of Ga-DOTATOC PET/CT to localize the culprit tumor inducing osteomalacia.
镓- DOTATOC PET/CT 对定位致骨软化症的元凶肿瘤的作用。
Sci Rep. 2021 Jan 19;11(1):1819. doi: 10.1038/s41598-021-81491-2.
4
Peptide Receptor Radionuclide Therapy for a Phosphaturic Mesenchymal Tumor.肽受体放射性核素治疗磷酸尿性间叶肿瘤
Case Rep Oncol. 2020 Nov 30;13(3):1373-1380. doi: 10.1159/000510334. eCollection 2020 Sep-Dec.
5
Tumor-Induced Osteomalacia.肿瘤相关性骨软化症。
Calcif Tissue Int. 2021 Jan;108(1):128-142. doi: 10.1007/s00223-020-00691-6. Epub 2020 Jun 5.
6
Physiological Actions of Fibroblast Growth Factor-23.成纤维细胞生长因子-23的生理作用
Front Endocrinol (Lausanne). 2018 May 28;9:267. doi: 10.3389/fendo.2018.00267. eCollection 2018.
7
Diagnostic performance and impact on patient management of Ga-DOTA-TOC PET/CT for detecting osteomalacia-associated tumours.镓- DOTATOC PET/CT 检测骨软化症相关肿瘤的诊断性能及其对患者管理的影响。
Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1710-1720. doi: 10.1007/s00259-018-3971-x. Epub 2018 Mar 12.
8
Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients.与磷尿性间叶肿瘤相关的肿瘤性骨软化症的治疗及预后:12例患者的回顾性分析
BMC Musculoskelet Disord. 2017 Sep 21;18(1):403. doi: 10.1186/s12891-017-1756-1.
9
Tumour-induced osteomalacia.肿瘤相关性骨软化症。
Nat Rev Dis Primers. 2017 Jul 13;3:17044. doi: 10.1038/nrdp.2017.44.
10
Nuclear Medicine in Patients with NET: Radiolabeled Somatostatin Analogues and their Brothers.神经内分泌肿瘤患者的核医学:放射性标记的生长抑素类似物及其同类物
Curr Radiopharm. 2017;10(2):74-84. doi: 10.2174/1874471010666170323115136.